
US Ebola Response Criticized for Slowness and Poor Organization
Summary
- Over 2,500 deaths recorded in DRC Ebola outbreak, with cases reported in six provinces.
- WHO recommends full-scale human trial of Ervebo vaccine to determine its effectiveness against Bundibugyo strain.
- DRC to receive 70,000 doses of Ervebo vaccine, which has been shown to be effective against Zaire strain.
- Ebola outbreak is spreading rapidly, with virus growing exponentially and cases reported in neighboring Uganda.
What Happened
The epidemic is spreading widely. It's now covering an area that is bigger than France. … It is growing faster and wider than the Ebola response.
The Democratic Republic of Congo (DRC) is facing its largest Ebola outbreak in history, with over 2,500 deaths recorded. The outbreak is spreading rapidly, with cases reported in six provinces, including near the border with South Sudan and in neighboring Uganda. According to Julien Harneis, the senior U.N. coordinator on the disease, the virus is growing exponentially, with half of the deaths occurring in the past 20 days. The DRC's 17th Ebola outbreak has been spreading for several weeks before it was officially declared on May 15, and has hit regions where the state presence is weak and health infrastructure is lacking.
The World Health Organization (WHO) has recommended a full-scale human trial of the Ervebo vaccine to determine its effectiveness against the Bundibugyo strain. The WHO also announced that the DRC would receive 70,000 doses of the Ervebo vaccine, which has been shown to be effective against the more common Zaire strain.
Legal Context
The slow and disorganized response to the Ebola outbreak in the DRC may create compliance exposures for companies operating in regions with weak state presence. Lawyers advising clients on international business or travel should be aware of these potential risks, particularly given the lack of approved vaccines or specific treatments for the Bundibugyo virus strain. The WHO's recommendation for a human trial of the Ervebo vaccine highlights the need for a more effective response to the outbreak.
The DRC's 17th Ebola outbreak has been criticized for its slowness and poor organization, with Doctors Without Borders cautioning that the outbreak is spreading at an alarming rate. The WHO has also faced criticism over its response, which has been hampered by mistrust among the population.
Why It Matters
The Ebola outbreak in the DRC highlights the need for a more effective global health infrastructure. The slow and disorganized response to the outbreak may have far-reaching consequences, including compliance exposures for companies operating in regions with weak state presence. The WHO's recommendation for a human trial of the Ervebo vaccine underscores the importance of developing effective treatments and vaccines for Ebola.
The outbreak also raises questions about the role of international organizations in responding to public health crises. The WHO's response has been criticized, but it is clear that more needs to be done to address the spread of the virus.
Practical Implications
Lawyers advising clients on international business or travel should be aware that the US government's slow and disorganized response to the Ebola outbreak in DRC may create compliance exposures, particularly for companies operating in regions with weak state presence.
Source
Source: Original reporting via AP
How does this affect you?
Get an AI analysis of this article grounded in your jurisdictions, practice areas, and any policy documents you've uploaded to Wansom.
Wansom is AI and can make mistakes.
